New Market Study Published: Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2012
Global Markets Direct's, 'Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Leishmaniasis (Kala-Azar), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leishmaniasis (Kala-Azar). Leishmaniasis (Kala-Azar) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release